Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

Negotiators at a U.N. conference in Colombia agreed to launch a fund for companies that make money from nature to give a ...

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

Bayer’s BREEZE 2 has a useful on-board disc ... the BREEZE 2 can test with ease and keep better control of diabetes.

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

For decades, drugmakers and researchers have found lifesaving medical advances in dozens of plants, animals and other ...

Patients with diabetes mellitus have a high risk of cardiovascular ... SE Kjeldsen has received honoraria from AstraZeneca, Bayer, Boehringer-Ingelheim, Leo, Medtronic, Nycomed and Takeda, and ...